| PubMed: | Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters. |
| PubMed: | Current Treatment Options for Osteoarthritis. |
| PubMed: | Diacerein inhibits Estradiol-benzoate induced cervical hyperkeratosis in female rats. |
| PubMed: | Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial. |
| PubMed: | Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. |
| PubMed: | Quantitative analysis of anti-inflammatory drugs using FTIR-ATR spectrometry. |
| PubMed: | Erratum to: Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO. |
| PubMed: | Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells. |
| PubMed: | The role of interleukin-1b and its antagonist (diacerein) in estradiol benzoate-induced endometrial hyperplasia and atypia in female rats. |
| PubMed: | Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control. |
| PubMed: | Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. |
| PubMed: | Evaluation of superabsorbent linseed-polysaccharides as a novel stimuli-responsive oral sustained release drug delivery system. |
| PubMed: | Development, characterization and in vitro evaluation of biodegradable rhein-loaded microparticles for treatment of osteoarthritis. |
| PubMed: | Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial. |
| PubMed: | Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. |
| PubMed: | Ultrasonic Processing Technique as a Green Preparation Approach for Diacerein-Loaded Niosomes. |
| PubMed: | Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. |
| PubMed: | Suppression of Cartilage Degradation by Zingerone Involving the p38 and JNK MAPK Signaling Pathway. |
| PubMed: | [The Analysis of Efficacy of The Application of Interleukin-1 Inhibitor in the Complex Therapy of Secondary Osteoarthritis Taking Into Account the Dynamics of Clinical and Functional Indicators]. |
| PubMed: | Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice. |
| PubMed: | In Vitro Chondroprotective Potential of Extracts Obtained from Various Phyllantus Species. |
| PubMed: | Non-surgical treatments for the management of early osteoarthritis. |
| PubMed: | Melanosis coli due to diacerein. |
| PubMed: | Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats. |
| PubMed: | Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO. |
| PubMed: | Lecithin-gold hybrid nanocarriers as efficient and pH selective vehicles for oral delivery of diacerein-In-vitro and in-vivo study. |
| PubMed: | Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study. |
| PubMed: | Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer. |
| PubMed: | Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation. |
| PubMed: | Multi-drug intoxication fatality involving atorvastatin: A case report. |
| PubMed: | Diacerein reduces joint damage, pain behavior and inhibits transient receptor potential vanilloid 1, matrix metalloproteinase and glial cells in rat spinal cord. |
| PubMed: | Design and synthesis of aloe-emodin derivatives as potent anti-tyrosinase, antibacterial and anti-inflammatory agents. |
| PubMed: | Diacerein protects against iodoacetate-induced osteoarthritis in the femorotibial joints of rats. |
| PubMed: | Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats. |
| PubMed: | Development and Pharmacokinetic Evaluation of New Oral Formulations of Diacerein. |
| PubMed: | Effects of diacerein on cartilage and subchondral bone in early stages of osteoarthritis in a rabbit model. |
| PubMed: | [Treatment for knee osteoarthritis in patients with oxalate nephropathy]. |
| PubMed: | Combination Therapies of Diacerein and Febuxostat Inhibit IL-1β Responses and Improve Clinical Symptoms in Patients With Refractory Gout. |
| PubMed: | Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery. |
| PubMed: | Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits. |
| PubMed: | Diacerein. A controversial EU re-evaluation upholds marketing authorisation, unfortunately. |
| PubMed: | Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior. |
| PubMed: | Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis. |
| PubMed: | Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. |
| PubMed: | Diacerein-Loaded novel gastroretentive nanofiber system using PLLA: Development and in vitro characterization. |
| PubMed: | Diacerein improves left ventricular remodeling and cardiac function by reducing the inflammatory response after myocardial infarction. |
| PubMed: | Celecoxib Combined with Diacerein Effectively Alleviates Osteoarthritis in Rats via Regulating JNK and p38MAPK Signaling Pathways. |
| PubMed: | Diacerein-thymol prodrug: in vivo release and pharmacological screening in experimental models of osteoarthritis in Wistar rats. |
| PubMed: | Benefit-risk assessment of diacerein in the treatment of osteoarthritis. |
| PubMed: | Supplementary methods in the nonsurgical treatment of osteoarthritis. |
| PubMed: | [Correction of an inflammatory process with an interleukin-1 inhibitor in the combination treatment of secondary osteoarthritis in the presence of comorbid condition]. |
| PubMed: | Chondroprotective potential of Phyllanthus amarus Schum. & Thonn. in experimentally induced cartilage degradation in the explants culture model. |
| PubMed: | Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain. |
| PubMed: | Experimental osteoarthritis model by means of medial meniscectomy in rats and effects of diacerein administration and hyaluronic acid injection. |
| PubMed: | Combination of diacerhein and antiepileptic drugs after local peripheral, and oral administration in the rat formalin test. |
| PubMed: | Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. |
| PubMed: | The disease modifying osteoarthritis drug diacerein is able to antagonize pro inflammatory state of chondrocytes under mild mechanical stimuli. |
| PubMed: | Stability-indicating HPLC method for quantification of celecoxib and diacerein along with its impurities in capsule dosage form. |
| PubMed: | Rhein exerts pro- and anti-inflammatory actions by targeting IKKβ inhibition in LPS-activated macrophages. |
| PubMed: | Spectroscopic characterization of both aqueous and solid-state diacerhein/hydroxypropyl-β-cyclodextrin inclusion complexes. |
| PubMed: | Simultaneous spectrophotometric determination of celecoxib and diacerein in bulk and capsule by absorption correction method and chemometric methods. |
| PubMed: | Diacerein for osteoarthritis. |
| PubMed: | Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. |
| PubMed: | OARSI guidelines for the non-surgical management of knee osteoarthritis. |
| PubMed: | [The pathogenetic substantiation of new therapeutic approach to the treatment of secondary osteoarthritis in patients with rheumatoid arthritis with basis therapy]. |
| PubMed: | The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination. |
| PubMed: | Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects. |
| PubMed: | Disease-modifying effect of anthraquinone prodrug with boswellic acid on collagenase-induced osteoarthritis in Wistar rats. |
| PubMed: | Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study. |
| PubMed: | The efficacy of diacerein in hand osteoarthritis: a double-blind, randomized, placebo-controlled study. |
| PubMed: | Disease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation. |
| PubMed: | The pathogenetic role of IL-1β in severe epidermolysis bullosa simplex. |
| PubMed: | Validated stability indicating TLC-densitometric method for the determination of diacerein. |
| PubMed: | Studies on synthesis, stability, release and pharmacodynamic profile of a novel diacerein-thymol prodrug. |
| PubMed: | Synthesis and pharmacokinetic profile of rhein- boswellic acid conjugate. |
| PubMed: | Nutraceuticals in the management of osteoarthritis : a critical review. |
| PubMed: | [Clinical study of Qianggu granule and diacerein capsule in treating knee osteoarthritis]. |
| PubMed: | Chondromodulating chimeric prodrugs of diacetylrhein: synthesis and evaluation in monoiodoacetate-induced hyperalgesia. |
| PubMed: | Diacerhein attenuates the inflammatory response and improves survival in a model of severe sepsis. |
| PubMed: | Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system. |
| PubMed: | Diacerein decreases visceral pain through inhibition of glutamatergic neurotransmission and cytokine signaling in mice. |
| PubMed: | [Management of osteoarthritis: oral therapies]. |
| PubMed: | Combined effect of subchondral drilling and hyaluronic acid with/without diacerein in full-thickness articular cartilage lesion in rabbits. |
| PubMed: | Fast-dissolving and high-drug-loaded, Fatty Acid-based self-emulsifying solid dispersions of diacerein. |
| PubMed: | Diacerein: a potential therapeutic drug for periodontal disease. |
| PubMed: | [Clinical efficacy of bushen huoxue qubi decoction on treatment of knee-osteoarthritis and its effect on hemarheology, anti-inflammation and antioxidation]. |
| PubMed: | Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee. |
| PubMed: | Comment on: Ramos-Zavala et al. Effect of diacerein on insulin secretion and metabolic control in drug-naïve patients with type 2 diabetes: a randomized clinical trial. Diabetes Care 2011;34:1591-1594. |
| PubMed: | Quantitative estimation of diacerein in bulk and in capsule formulation using hydrotropic solubilizing agents by UV-spectrophotometry and the first order derivative using the area under curve method. |
| PubMed: | A comparison of the therapeutic efficacy of diclofenac in osteoarthritis: a systematic review of randomised controlled trials. |
| PubMed: | [Pharmacological therapies for osteoarthritis]. |
| PubMed: | Rhein: a potential biological therapeutic drug for intervertebral disc degeneration. |
| PubMed: | Diacerhein improves glucose tolerance and insulin sensitivity in mice on a high-fat diet. |
| PubMed: | Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trial. |
| PubMed: | Stability-indicating spectrophotometric and spectrodensitometric methods for the determination of diacerein in the presence of its degradation product. |
| PubMed: | Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000. |
| PubMed: | Changes of body weight and inflammatory markers after 12-week intervention trial: results of a double-blind, placebo-control pilot study. |
| PubMed: | Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue. |
| PubMed: | Visible spectrophotometric estimation of diacerein in bulk and pharmaceutical dosage forms. |
| PubMed: | Stress degradation studies and development of a validated stability-indicating-assay-method for determination of diacerein in presence of degradation products. |
| PubMed: | Improvement in the dissolution profile of diacerein using a surfactant-based solid dispersion technique. |
| PubMed: | Are FoxO transcription factors implicated in osteoarthritis? Influence of Diacerhein. |
| PubMed: | Effects of diacerein at the molecular level in the osteoarthritis disease process. |
| PubMed: | A stability-indicating high performance liquid chromatographic method for the determination of diacerein in capsules. |
| PubMed: | Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials. |
| PubMed: | Diacerein decreases TNF-alpha and IL-1beta levels in peritoneal fluid and prevents Baker's yeast-induced fever in young rats. |
| PubMed: | Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trial. |
| PubMed: | Aloe-emodin-induced DNA fragmentation in the mouse in vivo comet assay. |
| PubMed: | Anti-inflammatory and anti-peroxidative roles of diacerein are possibly mediated through an alteration in thyroid functions in animal model of inflammation. |
| PubMed: | Simultaneous HPLC-UV determination of rhein and aceclofenac in human plasma. |
| PubMed: | Rhein, the metabolite of diacerhein, reduces the proliferation of osteoarthritic chondrocytes and synoviocytes without inducing apoptosis. |
| PubMed: | [Non-surgical treatment of osteoarthritis of large joints - new aspects]. |
| PubMed: | Self-reported prevalence of psoriasis and evaluation of the impact on the natural history of hip osteoarthritis: results of a 10 years follow-up study of 507 patients (ECHODIAH study). |
| PubMed: | Physico-chemical and structural characterization of diacerhein. |
| PubMed: | Isolation and structural elucidation of two impurities from a diacerein bulk drug. |
| PubMed: | Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. |
| PubMed: | [Treatment of osteoarthritis with drugs and other modalities]. |
| PubMed: | In vitro inhibition of IL-1beta catabolic effects on cartilage: a mechanism involved on diacerein anti-OA properties. |
| PubMed: | Bioequivalence study of two capsule formulations containing diacerein 50 mg in healthy human subjects. |
| PubMed: | Comment on: comparison between chondroprotective effects of glucosamine, curcumin and diacerein in IL-1beta-stimulated C-28/I2 chondrocytes. |
| PubMed: | An open prospective study on postmarketing evaluation of the efficacy and tolerability of diacerein in osteo-arthritis of the knee (DOK). |
| PubMed: | Clinical review of chondroitin sulfate in osteoarthritis. |
| PubMed: | The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon? |
| PubMed: | Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling. |
| PubMed: | In vitro effects of diacerein on NO production by chondrocytes in response to proinflammatory mediators. |
| PubMed: | Diacerhein downregulate proinflammatory cytokines expression and decrease the autoimmune diabetes frequency in nonobese diabetic (NOD) mice. |
| PubMed: | [Effectiveness of drugs used in degenerative joint diseases (arthroses)]. |
| PubMed: | Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast--comparison to its effects on osteoarthritic chondrocytes. |
| PubMed: | Comparison between chondroprotective effects of glucosamine, curcumin, and diacerein in IL-1beta-stimulated C-28/I2 chondrocytes. |
| PubMed: | On "Effectiveness of nonpharmacological and nonsurgical interventions..." Moe et al. Phys Ther. 2008;88: 1716-1727. |
| PubMed: | OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. |
| PubMed: | The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. |
| PubMed: | [Review of the evidence about drugs used as SYSADOA]. |
| PubMed: | DMOAD developments: present and future. |
| PubMed: | Effectiveness of nonpharmacological and nonsurgical interventions for hip osteoarthritis: an umbrella review of high-quality systematic reviews. |
| PubMed: | Nutraceuticals in the management of osteoarthritis. |
| PubMed: | Direct spectrophotometric determination of diacerhein in capsules. |
| PubMed: | Review: diacerein is more effective than placebo and is as effective as NSAIDs for knee and hip osteoarthritis. |
| PubMed: | The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study. |
| PubMed: | Selection of reliable reference genes for qPCR studies on chondroprotective action. |
| PubMed: | Diacerhein versus glucosamine in a rat model of osteoarthritis. |
| PubMed: | A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. |
| PubMed: | [Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action]. |
| PubMed: | IL-1beta synthesis by chondrocyte analyzed by 3D microscopy and flow cytometry: effect of Rhein. |
| PubMed: | Studies in animal models of osteoarthritis as predictors of a structure-modifying effect of diacerhein in humans with osteoarthritis. |
| PubMed: | Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for Diacerein effects in osteoarthritis. |
| PubMed: | Evaluation of efficacy and safety of diacerein in knee osteoarthritis in Chinese patients. |
| PubMed: | Effect of oral diacerein (DAR) in an experimental hip chondrolysis model. |
| PubMed: | Diacerein for osteoarthritis. |
| PubMed: | Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. |
| PubMed: | The effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice. |
| PubMed: | Chondroprotective drugs in degenerative joint diseases. |
| PubMed: | Heat-shock proteins and their role in chondrocyte protection, an application for autologous transplantation. |
| PubMed: | Osteoarthritis: an overview of the disease and its treatment strategies. |
| PubMed: | Tissue engineering of human cartilage and osteochondral composites using recirculation bioreactors. |
| PubMed: | Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. |
| PubMed: | Disease modification in osteoarthritis: are drugs the answer? |
| PubMed: | A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance. |
| PubMed: | [Pharmacological treatment of osteoarthritis. Expectations and reality]. |
| PubMed: | Future treatment of osteoarthritis. |
| PubMed: | Diacerein has a structure/disease-modifying effect on hip osteoarthritis. |
| PubMed: | Expedient total syntheses of rhein and diacerhein via Fries rearrangement. |
| PubMed: | Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. |
| PubMed: | [Mechanisms of action of diacerein, the first inhibitor of interleukin-1 in osteoarthritis]. |
| PubMed: | [Total hip arthroplasty indication, evaluation criteria for structure modifying trials. Lessons from the ECHODIAH and PHARE studies]. |
| PubMed: | [Chondromodulation in 2003: dream or reality?]. |
| PubMed: | Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. |
| PubMed: | Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols. |
| PubMed: | Measurement of structure (disease) modification in osteoarthritis. |
| PubMed: | Determination of chromium and selected elements in multimineral and multivitamin preparations and in pharmaceutical raw material. |
| PubMed: | New perspectives in the management of osteoarthritis. structure modification: facts or fantasy? |
| PubMed: | Long-term treatment with diacerein has a structure/disease modifying effect on hip osteoarthritis. |
| PubMed: | Diacerein reduces the level of cartilage chondrocyte DNA fragmentation and death in experimental dog osteoarthritic cartilage at the same time that it inhibits caspase-3 and inducible nitric oxide synthase. |
| PubMed: | The true results of the ECHODIAH study with diacerein. |
| PubMed: | [Clinical and radiographic status of patients in the ECHODIAH study who underwent THA Pertinence of the pain-function index for operative decision making]. |
| PubMed: | [Comparison of the pharmacologic effect of diacerein and a selective COX-2 inhibitor in the mouse induced-granuloma model]. |
| PubMed: | [Efficacy of diacerein on the symptoms and radiographic progression of osteoarthritis]. |
| PubMed: | Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. |
| PubMed: | Diacerhein and rhein prevent interleukin-1beta-induced nuclear factor-kappaB activation by inhibiting the degradation of inhibitor kappaB-alpha. |
| PubMed: | Oral and intra-articular remedies: Review of papers published from March 2001 to February 2002. |
| PubMed: | Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption. |
| PubMed: | In vitro study of intracellular IL-1beta production and beta1 integrins expression in stimulated chondrocytes--effect of rhein. |
| PubMed: | COX-1, COX-2 and articular joint disease: a role for chondroprotective agents. |
| PubMed: | [Current therapeutic possibilities in the treatment of arthrosis]. |
| PubMed: | [Total hip replacement: a criterion of coxarthrosis evaluation?]. |
| PubMed: | [Results of the ECHODIAH clinical trial on hip arthrosis]. |
| PubMed: | [Current medical possibilities in the treatment of arthrosis]. |
| PubMed: | Effects of diacerein on indomethacin-induced gastric ulceration. |
| PubMed: | Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. |
| PubMed: | Innovative therapies in osteoarthritis. |
| PubMed: | Diacerein as a disease-modulating agent in osteoarthritis. |
| PubMed: | Pharmacological therapy of osteoarthritis. |
| PubMed: | [Case report of fatal hepatitis from diacerein]. |
| PubMed: | Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis. |
| PubMed: | [Pharmacy clinics. How I treat...Osteoarthritis. 2nd part: new therapeutic perspectives]. |
| PubMed: | The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis. |
| PubMed: | Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone. |
| PubMed: | Reports of equivalence trials should not mask negative or mediocre results. |
| PubMed: | Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes. |
| PubMed: | A novel microassay for the quantitation of the sulfated glycosaminoglycan content of histological sections: its application to determine the effects of Diacerhein on cartilage in an ovine model of osteoarthritis. |
| PubMed: | Pharmacologic pain treatment of musculoskeletal disorders: current perspectives and future prospects. |
| PubMed: | [Preclinical development of a medication: application to diacerhein]. |
| PubMed: | Rhein, an active metabolite of diacerein, suppresses the interleukin-1alpha-induced proteoglycan degradation in cultured rabbit articular chondrocytes. |
| PubMed: | Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. |
| PubMed: | Harpagophytum procumbens in the treatment of knee and hip osteoarthritis. Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. |
| PubMed: | Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. |
| PubMed: | Synergistic antiinflammatory effect of NF-kappaB inhibitors and steroidal or non steroidal antiinflammatory drugs in the pleural inflammation induced by carrageenan in mice. |
| PubMed: | Effects of diacerein on biosynthesis activities of chondrocytes in culture. |
| PubMed: | Diacerhein and rhein reduce the ICE-induced IL-1beta and IL-18 activation in human osteoarthritic cartilage. |
| PubMed: | Effect of diacerein on spontaneous polyarthritis in male New Zealand black/KN mice. |
| PubMed: | Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. |
| PubMed: | Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. |
| PubMed: | Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1. |
| PubMed: | Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis. |
| PubMed: | [Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis]. |
| PubMed: | [Evaluation of the effects of diacerhein in the sheep model of arthritis]. |
| PubMed: | Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. |
| PubMed: | Clinical pharmacokinetics of diacerein. |
| PubMed: | Diacerhein blocks iron regulatory protein activation in inflamed human monocytes. |
| PubMed: | [Assessment of the placebo effect of symptomatic slow-acting anti-arthritics]. |
| PubMed: | [Functional manifestations of osteoarthritis: key points to the clinical efficacy of diacerhein]. |
| PubMed: | Fatal toxic epidermal necrosis: responsibility of diacerein? A controversy. |
| PubMed: | Effects of diacerhein on granuloma induced cartilage breakdown in the mouse. |
| PubMed: | In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. |
| PubMed: | Effects of diacerhein in an accelerated canine model of osteoarthritis. |
| PubMed: | [Pragmatic study of diacerhein: results on clinical signs, quality of life and medico-economic costs]. |
| PubMed: | [Effects of diacerhein on canine model with accelerated osteoarthritis]. |
| PubMed: | [Effects of diacerhein on cytokine determinations in a model of cartilage degradation induced by granuloma in mice]. |
| PubMed: | [Anti-interleukin-1 effects of diacerhein in vitro]. |
| PubMed: | [Natural history of coxarthrosis: epidemiological data from the ECHODIAH study]. |
| PubMed: | Medico-economic analysis of diacerein with or without standard therapy in the treatment of osteoarthritis. |
| PubMed: | Effect of diacetylrhein on the development of experimental osteoarthritis. A biochemical investigation. |
| PubMed: | [Acute hepatitis asociated with ingestion of of diacerein]. |
| PubMed: | Diacerein. |
| PubMed: | Effect of diacetyl rhein on the development of experimental osteoarthritis. A biochemical investigation. |
| PubMed: | [Why pragmatic trials of the treatment of osteoarthritis? Application to the pragmatic study of diacetylrhein]. |
| PubMed: | [Diacetylrhein administrated "curatively" in an experimental model of post-contusion osteoarthritis in rabbits]. |
| PubMed: | [Evaluation methods of osteoarthritis: apropos of the ECHODIAH study]. |
| PubMed: | [Study of ART 50 in daily rheumatological practice]. |
| PubMed: | [Beneficial effects of treatment with diacerhein in guinea pigs with osteoarthritis]. |
| PubMed: | [Molecular mechanisms implicated in the inhibition of collagenase expression by diacerheine]. |
| PubMed: | [Severe diarrhea with hypokalemia attributed to diacetylrhein]. |
| PubMed: | [A new drug for arthroses]. |
| PubMed: | [Study of ART 50 in everyday rheumatic practice]. |
| PubMed: | Diacerhein in the treatment of osteoarthritis of the hip. |
| PubMed: | Influence of renal function on the pharmacokinetics of diacerein after a single oral dose. |
| PubMed: | Pharmacokinetics of diacerein in patients with liver cirrhosis. |
| PubMed: | [Diacetylrhein, a new therapeutic approach of osteoarthritis]. |
| PubMed: | [Diacetylrhein on a postcontusion model of experimental osteoarthritis in the rabbit]. |
| PubMed: | [Effect of diacerhein (ART 50) on the matrix synthesis and collagenase secretion by cultured joint chondrocytes in rabbits]. |
| PubMed: | Influence of renal function on the pharmacokinetics of diacerein after a single oral dose. |
| PubMed: | Antireactive properties of "chondroprotective" drugs. |
| PubMed: | [Fangotherapy and diacerein in the treatment of osteoarthrosis of the hip and knee]. |
| PubMed: | Diacetylrhein and rhein: in vivo and in vitro effect on lymphocyte membrane fluidity. |
| PubMed: | Modulation of urokinase receptors on human synovial cells and osteoarthritic chondrocytes by diacetylrhein. |
| PubMed: | [Clinical evaluation of diacerein in the treatment of osteoarthrosis]. |
| PubMed: | Effects of diacerein on the quantity and phagocytic activity of thioglycollate-elicited mouse peritoneal macrophages. |
| PubMed: | Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. |
| PubMed: | Simple method for the determination of rhein in biological fluids by high-performance liquid chromatography. |
| PubMed: | Effect of diacetylrhein on the phagocytosis of polymorphonuclear leucocytes and its influence on the biosynthesis of hyaluronate in synovial cells. |
| PubMed: | [Drug therapy of arthrosis]. |
| PubMed: | Rhein: an anthraquinone that modulates superoxide anion production from human neutrophils. |
| PubMed: | [Endoscopic evaluation of the effects of diacerhein and naproxen on the gastroduodenal mucosa]. |
| PubMed: | [Diacereine: an original approach in the treatment of degenerative and/or extra-articular rheumatism]. |
| PubMed: | Studies in vitro on the effects of rhein on the chemotaxis of human leukocytes. |
| PubMed: | Experimental studies on diacerhein: effects on the phagocytosis of neutrophil cells from subcutaneous carrageenan-induced exudate. |
| PubMed: | [Influence of diacereine on the gastroduodenal mucosa of ulcer patients in remission and on the diuresis of cirrhosis ascites patients]. |
| PubMed: | [Diacerein]. |
| PubMed: | [Diacetylrhein in the treatment of degenerative arthropathies]. |
| PubMed: | A non steroidal anti-inflammatory drug that stimulates prostaglandin release. |
| PubMed: | Preliminary experience with diacetylrhein in the treatment of osteoarthritis. |